List of works - Sara Grazia Maria Piccirillo

A review of the role of stem cells in the development and treatment of glioma.

scientific article published on 20 April 2012

ATPS-93CHEMO-NAÏVE GLIOBLASTOMA PATIENTS CONTAIN GENETICALLY HETEROGENEOUS SUB-CLONES CAPABLE OF TUMOUR PROPAGATION AND SPATIALLY HETEROGENEOUS DRUG-RESISTANT CELL POPULATIONS.

scientific article

Assessing and monitoring intratumor heterogeneity in glioblastoma: how far has multimodal imaging come?

scientific article

Basic and Translational Advances in Glioblastoma.

scientific article

Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells.

scientific article published on December 2006

Bone morphogenetic proteins regulate tumorigenicity in human glioblastoma stem cells

scientific article published on 01 January 2006

Brain cancer stem cells.

scientific article published on 29 September 2009

CB-18INTERROGATION OF SUB-CLONAL GENETIC DIVERSITY OF HUMAN GBM REVEALS GENETIC HETEROGENEITY IN TUMOUR-PROPAGATING CELLS, WHICH DISPLAY VARIABLE COMPETITIVE CAPACITY FOR TUMOUR PROPAGATION IN VIVO

CD15 Expression Does Not Identify a Phenotypically or Genetically Distinct Glioblastoma Population

scientific article

COMPLEX EVOLUTIONARY DYNAMICS GENERATES GENETIC DIVERSITY AND INTRA-TUMOR HETEROGENEITY IN INDIVIDUAL PATIENTS WITH GLIOBLASTOMA.

scientific article published in July 2014

Cisplatin-tethered gold nanospheres for multimodal chemo-radiotherapy of glioblastoma

scientific article published on 13 August 2014

Clonal diversity in glioblastoma: is it clinically relevant?

scientific article published in January 2015

Corrigendum

Cyclopamine-mediated hedgehog pathway inhibition depletes stem-like cancer cells in glioblastoma

scientific article (publication date: October 2007)

DD-06POTENTIATING THE THERAPEUTIC EFFICIENCY OF THE ALKYLATING CHEMOTHERAPY TEMOZOLOMIDE IN PATIENTS WITH GLIOBLASTOMA

scientific article published in November 2014

DNER, an epigenetically modulated gene, regulates glioblastoma-derived neurosphere cell differentiation and tumor propagation.

scientific article

EGFRvIII mutations can emerge as late and heterogenous events in glioblastoma development and promote angiogenesis through Src activation.

scientific article published on 10 June 2016

Fluorescence-guided surgical sampling of glioblastoma identifies phenotypically distinct tumour-initiating cell populations in the tumour mass and margin.

scientific article

Glioblastoma cell growth is suppressed by disruption of Fibroblast Growth Factor pathway signaling.

scientific article published on 2 April 2009

Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics.

scientific article published on 14 February 2013

NG2 expression in glioblastoma identifies an actively proliferating population with an aggressive molecular signature.

scientific article

NOTCH pathway blockade depletes CD133-positive glioblastoma cells and inhibits growth of tumor neurospheres and xenografts

scientific article

O11TRANSCRIPTIONAL PROFILING OF DISTINCT COMPARTMENTS IN HUMAN GLIOBLASTOMA REVEALS KEY DYSREGULATED PATHWAYS.

scientific article published in October 2014

O4.05GENETIC DIVERSITY AND INTRA-TUMOR HETEROGENEITY IN HUMAN GLIOBLASTOMA.

scientific article published in September 2014

OP08CHARACTERISATION OF RESIDUAL CELLS IN GLIOBLASTOMA MULTIFORME

OP14GENETIC AND FUNCTIONAL DIVERSITY OF PROPAGATING CELLS IN GLIOBLASTOMA.

scientific article

Oncogenes Activate an Autonomous Transcriptional Regulatory Circuit That Drives Glioblastoma.

scientific article published on January 2017

P03.04SENSITIZING GLIOBLASTOMA CELLS TO THERAPY BY TARGETING THE L-GLUTAMATE/L-CYSTINE ANTIPORTER SYSTEM XC-.

scientific article published in September 2014

P49SENSITIZING GLIOBLASTOMA CELLS TO THERAPY BY TARGETING THE L-GLUTAMATE/L-CYSTINE ANTIPORTER SYSTEM XC-

Podocalyxin-like protein is expressed in glioblastoma multiforme stem-like cells and is associated with poor outcome.

scientific article

Resveratrol: A new potential therapeutic agent for melanoma?

scientific article published on 11 December 2019

The role of sub-ventricular zone in gliomagenesis.

scientific article published in October 2015

List of works by Sara Grazia Maria Piccirillo

A review of the role of stem cells in the development and treatment of glioma.

ATPS-93CHEMO-NAÏVE GLIOBLASTOMA PATIENTS CONTAIN GENETICALLY HETEROGENEOUS SUB-CLONES CAPABLE OF TUMOUR PROPAGATION AND SPATIALLY HETEROGENEOUS DRUG-RESISTANT CELL POPULATIONS.

Assessing and monitoring intratumor heterogeneity in glioblastoma: how far has multimodal imaging come?

Basic and Translational Advances in Glioblastoma.

Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells.

Bone morphogenetic proteins regulate tumorigenicity in human glioblastoma stem cells

Brain cancer stem cells.

CB-18INTERROGATION OF SUB-CLONAL GENETIC DIVERSITY OF HUMAN GBM REVEALS GENETIC HETEROGENEITY IN TUMOUR-PROPAGATING CELLS, WHICH DISPLAY VARIABLE COMPETITIVE CAPACITY FOR TUMOUR PROPAGATION IN VIVO

CD15 Expression Does Not Identify a Phenotypically or Genetically Distinct Glioblastoma Population

COMPLEX EVOLUTIONARY DYNAMICS GENERATES GENETIC DIVERSITY AND INTRA-TUMOR HETEROGENEITY IN INDIVIDUAL PATIENTS WITH GLIOBLASTOMA.

Cisplatin-tethered gold nanospheres for multimodal chemo-radiotherapy of glioblastoma

Clonal diversity in glioblastoma: is it clinically relevant?

Corrigendum

Cyclopamine-mediated hedgehog pathway inhibition depletes stem-like cancer cells in glioblastoma

DD-06POTENTIATING THE THERAPEUTIC EFFICIENCY OF THE ALKYLATING CHEMOTHERAPY TEMOZOLOMIDE IN PATIENTS WITH GLIOBLASTOMA

DNER, an epigenetically modulated gene, regulates glioblastoma-derived neurosphere cell differentiation and tumor propagation.

EGFRvIII mutations can emerge as late and heterogenous events in glioblastoma development and promote angiogenesis through Src activation.

Fluorescence-guided surgical sampling of glioblastoma identifies phenotypically distinct tumour-initiating cell populations in the tumour mass and margin.

Glioblastoma cell growth is suppressed by disruption of Fibroblast Growth Factor pathway signaling.

Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics.

NG2 expression in glioblastoma identifies an actively proliferating population with an aggressive molecular signature.

NOTCH pathway blockade depletes CD133-positive glioblastoma cells and inhibits growth of tumor neurospheres and xenografts

O11TRANSCRIPTIONAL PROFILING OF DISTINCT COMPARTMENTS IN HUMAN GLIOBLASTOMA REVEALS KEY DYSREGULATED PATHWAYS.

O4.05GENETIC DIVERSITY AND INTRA-TUMOR HETEROGENEITY IN HUMAN GLIOBLASTOMA.

OP08CHARACTERISATION OF RESIDUAL CELLS IN GLIOBLASTOMA MULTIFORME

OP14GENETIC AND FUNCTIONAL DIVERSITY OF PROPAGATING CELLS IN GLIOBLASTOMA.

Oncogenes Activate an Autonomous Transcriptional Regulatory Circuit That Drives Glioblastoma.

P03.04SENSITIZING GLIOBLASTOMA CELLS TO THERAPY BY TARGETING THE L-GLUTAMATE/L-CYSTINE ANTIPORTER SYSTEM XC-.

P49SENSITIZING GLIOBLASTOMA CELLS TO THERAPY BY TARGETING THE L-GLUTAMATE/L-CYSTINE ANTIPORTER SYSTEM XC-

Podocalyxin-like protein is expressed in glioblastoma multiforme stem-like cells and is associated with poor outcome.

Resveratrol: A new potential therapeutic agent for melanoma?

The role of sub-ventricular zone in gliomagenesis.